These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 29045308)
1. Thirty days only double antiplatelet therapy after drug-eluting stenting: could a 'short-term' treatment be advantageous? Casella G; Resciniti E; Gallo P J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e21-e25. PubMed ID: 29045308 [No Abstract] [Full Text] [Related]
2. Should all stent patients have prolonged dual antiplatelet therapy? Kirtane AJ; King SB JACC Cardiovasc Interv; 2015 May; 8(6):873-875. PubMed ID: 25999115 [No Abstract] [Full Text] [Related]
3. Sex Differences in the Clinical Impact of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents). Yu J; Mehran R; Baber U; Ooi SY; Witzenbichler B; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Brodie BR; Stuckey TD; Maehara A; Xu K; Ben-Yehuda O; Kirtane AJ; Stone GW Circ Cardiovasc Interv; 2017 Feb; 10(2):. PubMed ID: 28193677 [TBL] [Abstract][Full Text] [Related]
4. Is There an Ideal Level of Platelet P2Y12-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention?: "Window" Analysis From the ADAPT-DES Study (Assessment of Dual AntiPlatelet Therapy With Drug-Eluting Stents). Kirtane AJ; Parikh PB; Stuckey TD; Xu K; Witzenbichler B; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Brodie BR; Mazzaferri EL; Parvataneni R; Maehara A; Généreux P; Mehran R; Stone GW JACC Cardiovasc Interv; 2015 Dec; 8(15):1978-1987. PubMed ID: 26738669 [TBL] [Abstract][Full Text] [Related]
5. Dual Antiplatelet Therapy Continuation Beyond 1 Year After Drug-Eluting Stents: A Meta-Analysis of Randomized Trials. Ferrante G; Condorelli G; Pagnotta P; Reimers B Circ Cardiovasc Interv; 2017 May; 10(5):. PubMed ID: 28500135 [TBL] [Abstract][Full Text] [Related]
6. Shorter (≤6 months) versus longer (≥12 months) duration dual antiplatelet therapy after drug eluting stents: a meta-analysis of randomized clinical trials. Pandit A; Giri S; Hakim FA; Fortuin FD Catheter Cardiovasc Interv; 2015 Jan; 85(1):34-40. PubMed ID: 24753084 [TBL] [Abstract][Full Text] [Related]
7. Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry. Faggioni M; Baber U; Sartori S; Giustino G; Cohen DJ; Henry TD; Farhan S; Ariti C; Dangas G; Gibson M; Giacoppo D; Krucoff MW; Aquino M; Chandrasekhar J; Moliterno DJ; Colombo A; Vogel B; Chieffo A; Kini AS; Witzenbichler B; Weisz G; Steg PG; Pocock S; Mehran R JACC Cardiovasc Interv; 2017 Apr; 10(7):645-654. PubMed ID: 28330641 [TBL] [Abstract][Full Text] [Related]
8. Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of Drug-Eluting Stents in Subjects With Peripheral Arterial Disease: Analysis From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents). Gupta R; Kirtane AJ; Ozan MO; Witzenbichler B; Rinaldi MJ; Metzger DC; Weisz G; Stuckey TD; Brodie BR; Mehran R; Ben-Yehuda O; Stone GW Circ Cardiovasc Interv; 2017 Mar; 10(3):. PubMed ID: 28288963 [TBL] [Abstract][Full Text] [Related]
9. The saga of the duration of dual antiplatelet therapy after drug-eluting stent placement. Helft G Arch Cardiovasc Dis; 2015 Oct; 108(10):469-71. PubMed ID: 26432274 [No Abstract] [Full Text] [Related]
11. P2Y12 inhibitors in acute coronary syndrome: when to give them and when to prolong their use. Grotti S; Bolognese L J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e9-e12. PubMed ID: 29538137 [No Abstract] [Full Text] [Related]
12. Conversations in cardiology: bridging antiplatelet therapy before surgery. Kern MJ; Applegate RJ; Bell M; Brilakis ES; Butman SM; Bach RG; Kaul P; Klein LW; Krucoff MW; Moore JA; Price MJ; Rao SV; Stone GW; Uretsky BF Catheter Cardiovasc Interv; 2014 Apr; 83(5):748-52. PubMed ID: 24395180 [TBL] [Abstract][Full Text] [Related]
13. Reduced antiplatelet therapy after drug-eluting stenting: multicenter Janus Flex carbostent implantation with short dual antiplatelet treatment for 2 or 6 months-MATRIX study. Cassese S; De Luca G; Villari B; Berti S; Bellone P; Alfieri A; Montinaro A; Quaranta G; Marraccini P; Piscione F; Catheter Cardiovasc Interv; 2012 Sep; 80(3):408-16. PubMed ID: 21735531 [TBL] [Abstract][Full Text] [Related]
14. 6- Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin: Final Results of the ITALIC Trial (Is There a Life for DES After Discontinuation of Clopidogrel). Didier R; Morice MC; Barragan P; Noryani AAL; Noor HA; Majwal T; Hovasse T; Castellant P; Schneeberger M; Maillard L; Bressolette E; Wojcik J; Delarche N; Blanchard D; Jouve B; Ormezzano O; Paganelli F; Levy G; Sainsous J; Carrie D; Furber A; Berlan J; Darremont O; Le Breton H; Lyuycx-Bore A; Gommeaux A; Cassat C; Kermarrec A; Cazaux P; Druelles P; Dauphin R; Armengaud J; Dupouy P; Champagnac D; Ohlmann P; Ben Amer H; Kiss RG; Ungi I; Gilard M JACC Cardiovasc Interv; 2017 Jun; 10(12):1202-1210. PubMed ID: 28641840 [TBL] [Abstract][Full Text] [Related]
15. Risk of Early Adverse Events After Clopidogrel Discontinuation in Patients Undergoing Short-Term Dual Antiplatelet Therapy: An Individual Participant Data Analysis. Piccolo R; Feres F; Abizaid A; Gilard M; Morice MC; Hong MK; Kim HS; Colombo A; Bhatt DL; Palmerini T; Stone GW; Windecker S; Valgimigli M JACC Cardiovasc Interv; 2017 Aug; 10(16):1621-1630. PubMed ID: 28838471 [TBL] [Abstract][Full Text] [Related]